| 摘要 |
<p>The present invention pertains to methods for treating a patient who is at risk for a vascular (e.g., cardiovascular, cerebrovascular) event comprising administering to the patient an effective amount of a lipid-modifying drug. The present methods are particularly effective in patients having a lipid profile comprising a low Low Density Lipoprotein (LDL-C) and a low High Density Lipoprotein (HDL-C). Patients having low levels of LDL-C and HDL-C include diabetics. As a result, the present invention includes methods for treating diabetics by administering a lipid-modifying drug such as a fibric acid.</p> |
